Knudsen ES - Search Results

1

CDK4/6 inhibition antagonizes the cytotoxic response to anthracycline therapy.

McClendon AK, Dean JL, Rivadeneira DB, Yu JE, Reed CA, Gao E, Farber JL, Force T, Koch WJ, Knudsen ES. McClendon AK, et al. Among authors: knudsen es. Cell Cycle. 2012 Jul 15;11(14):2747-55. doi: 10.4161/cc.21127. Epub 2012 Jul 15. Cell Cycle. 2012. PMID: 22751436 Free PMC article.

2

RB in breast cancer: at the crossroads of tumorigenesis and treatment.

Bosco EE, Knudsen ES. Bosco EE, et al. Among authors: knudsen es. Cell Cycle. 2007 Mar 15;6(6):667-71. doi: 10.4161/cc.6.6.3988. Epub 2007 Mar 7. Cell Cycle. 2007. PMID: 17361100 Free article. Review.

3

RB loss abrogates cell cycle control and genome integrity to promote liver tumorigenesis.

Mayhew CN, Carter SL, Fox SR, Sexton CR, Reed CA, Srinivasan SV, Liu X, Wikenheiser-Brokamp K, Boivin GP, Lee JS, Aronow BJ, Thorgeirsson SS, Knudsen ES. Mayhew CN, et al. Among authors: knudsen es. Gastroenterology. 2007 Sep;133(3):976-84. doi: 10.1053/j.gastro.2007.06.025. Epub 2007 Jun 20. Gastroenterology. 2007. PMID: 17854601

4

RB status governs differential sensitivity to cytotoxic and molecularly-targeted therapeutic agents.

Stengel KR, Dean JL, Seeley SL, Mayhew CN, Knudsen ES. Stengel KR, et al. Among authors: knudsen es. Cell Cycle. 2008 Apr 15;7(8):1095-103. doi: 10.4161/cc.7.8.5737. Epub 2008 Feb 11. Cell Cycle. 2008. PMID: 18414045

5

Activation of the retinoblastoma tumor suppressor mediates cell cycle inhibition and cell death in specific cervical cancer cell lines.

Bourgo RJ, Braden WA, Wells SI, Knudsen ES. Bourgo RJ, et al. Among authors: knudsen es. Mol Carcinog. 2009 Jan;48(1):45-55. doi: 10.1002/mc.20456. Mol Carcinog. 2009. PMID: 18506774 Free PMC article.

6

Cyclin D1b is aberrantly regulated in response to therapeutic challenge and promotes resistance to estrogen antagonists.

Wang Y, Dean JL, Millar EK, Tran TH, McNeil CM, Burd CJ, Henshall SM, Utama FE, Witkiewicz A, Rui H, Sutherland RL, Knudsen KE, Knudsen ES. Wang Y, et al. Among authors: knudsen ke, knudsen es. Cancer Res. 2008 Jul 15;68(14):5628-38. doi: 10.1158/0008-5472.CAN-07-3170. Cancer Res. 2008. PMID: 18632615 Free PMC article.

7

Cyclin-dependent kinase 4/6 activity is a critical determinant of pre-replication complex assembly.

Braden WA, McClendon AK, Knudsen ES. Braden WA, et al. Among authors: knudsen es. Oncogene. 2008 Nov 27;27(56):7083-93. doi: 10.1038/onc.2008.319. Epub 2008 Sep 8. Oncogene. 2008. Retraction in: Oncogene. 2023 Apr;42(16):1332. doi: 10.1038/s41388-023-02663-0. PMID: 18776921 Retracted.

8

Tailoring to RB: tumour suppressor status and therapeutic response.

Knudsen ES, Knudsen KE. Knudsen ES, et al. Among authors: knudsen ke. Nat Rev Cancer. 2008 Sep;8(9):714-24. doi: 10.1038/nrc2401. Nat Rev Cancer. 2008. PMID: 19143056 Free PMC article. Review.

9

Cyclin D1b protein expression in breast cancer is independent of cyclin D1a and associated with poor disease outcome.

Millar EK, Dean JL, McNeil CM, O'Toole SA, Henshall SM, Tran T, Lin J, Quong A, Comstock CE, Witkiewicz A, Musgrove EA, Rui H, Lemarchand L, Setiawan VW, Haiman CA, Knudsen KE, Sutherland RL, Knudsen ES. Millar EK, et al. Among authors: knudsen ke, knudsen es. Oncogene. 2009 Apr 16;28(15):1812-20. doi: 10.1038/onc.2009.13. Epub 2009 Mar 16. Oncogene. 2009. PMID: 19287456 Free PMC article.

10

Modeling the effect of the RB tumor suppressor on disease progression: dependence on oncogene network and cellular context.

Dean JL, McClendon AK, Stengel KR, Knudsen ES. Dean JL, et al. Among authors: knudsen es. Oncogene. 2010 Jan 7;29(1):68-80. doi: 10.1038/onc.2009.313. Epub 2009 Oct 5. Oncogene. 2010. PMID: 19802012

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

200 results

Search Page

Filters